Linezolid-induced pure red cell aplasia: a case report and literature review

Linezolid (LZD) is the first oxazolidinone with excellent safety and efficacy profiles against refractory infections caused by gram-positive organisms. Hematological toxicities such as thrombocytopenia, anemia, and leukocytopenia are common in LZD therapy; however, LZD-induced pure red cell aplasia...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhuanbo, Xu, Ning, Wang, Yun, Huang, Xiaoping, Cao, Chao, Chen, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259366/
https://www.ncbi.nlm.nih.gov/pubmed/30270705
http://dx.doi.org/10.1177/0300060518800126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259366/
https://www.ncbi.nlm.nih.gov/pubmed/30270705
http://dx.doi.org/10.1177/0300060518800126

Ejemplares similares